Clinical trial
Toremifene With or Without Atamestane in Treating Postmenopausal Women With…
NCT00010322 · Intarcia Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00010322 |
|---|---|
| Title | Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer |
| Official title | Phase III Study of Atamestane Plus Toremifene in Metastatic Breast Cancer |
| Lead sponsor | Intarcia Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | atamestane, toremifene |
| Start date | Oct 1, 2000 |
| Primary completion | May 1, 2001 |
| Completion | May 1, 2001 |
| First posted | May 5, 2004 |
| Last update posted | Mar 26, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: